Is Royal Jelly Cardiometabolic Meta-Analysis safe?

Updated October 2026

Quick Answer

Royal Jelly Cardiometabolic Meta-Analysis has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Such interventions can help refine dietary and clinical guidelines, especially for individuals at high risk of NCDs [].

Key Takeaways

  • 01Such interventions can help refine dietary and clinical guidelines, especially for individuals at high risk of NCDs []. [Norouzzadeh Mostafa (2025)]
  • 02A 2023 meta-analysis reported that honey improved blood glucose and lipid parameters but also increased pro-inflammatory markers [], whereas a 2021 SRMA found no significant effect on lipid profiles []. [Norouzzadeh Mostafa (2025)]
  • 03found no general effect on anthropometric indices, but RJ at doses <3000&#8201;mg/day significantly improved anthropometric indices []. [Norouzzadeh Mostafa (2025)]
  • 041 2 1 3 Non-communicable diseases (NCDs) are responsible for an estimated 43 million deaths annually, disproportionately affecting low- and middle-income countries where nearly 73% of global NCDs-related mortality was recorded []. [Norouzzadeh Mostafa (2025)]
The current Migaku evidence database contains 1 reusable source document for Royal Jelly Cardiometabolic Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts. - Such interventions can help refine dietary and clinical guidelines, especially for individuals at high risk of NCDs []. [Norouzzadeh Mostafa (2025); evidence level 1] - A 2023 meta-analysis reported that honey improved blood glucose and lipid parameters but also increased pro-inflammatory markers [], whereas a 2021 SRMA found no significant effect on lipid profiles []. [Norouzzadeh Mostafa (2025); evidence level 1] - found no general effect on anthropometric indices, but RJ at doses <3000&#8201;mg/day significantly improved anthropometric indices []. [Norouzzadeh Mostafa (2025); evidence level 1] - 1 2 1 3 Non-communicable diseases (NCDs) are responsible for an estimated 43 million deaths annually, disproportionately affecting low- and middle-income countries where nearly 73% of global NCDs-related mortality was recorded []. [Norouzzadeh Mostafa (2025); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Dosage exploration of the effects of honey and its derivatives on cardiometabolic outcomes: an overview of systematic reviews and GRADE-assessed updated meta-analysis